Cost-effectiveness modeling of Dermagraft® for the treatment of diabetic foot ulcers the French context

Diabetes and Metabolism

Volumn 26, Issue 2, 2000, Pages 125-132

  Allenet, B ^a,b   Paree F ^e   Lebrun, T ^e   Carr, L ^e   Posnett, J ^e   Martini, J ^c   Yvon, C ^d  

^a CRESGE   (France)

^b UNIV LILLE   (France)

^c CHU RANGUEIL   (France)

^d Smith and Nephew Research Centre   (United Kingdom)

^e NONE

Author keywords

Cost effectiveness; Dermagraft ; Diabetic foot ulcer; Markov

Indexed keywords

AMPUTATION; ARTICLE; ARTIFICIAL SKIN; CELLULITIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; FOOT ULCER; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MODEL; MORTALITY; OSTEOMYELITIS; RECURRENT DISEASE; WOUND HEALING;

COST-BENEFIT ANALYSIS; DIABETIC FOOT; FRANCE; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; MARKOV CHAINS; MODELS, STATISTICAL; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN, ARTIFICIAL;

EID: 0034066856     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sonnaville JJ, Colly LP, Wijkel D, Heine RJ. The prevalence and determinants of foot ulceration in type II diabetic patients in primary health care setting. Diab Res Clin Pract, 1997, 35, 149-156.
2. Siitonen OI, Nishkanen LK, Laakso M et al. Lower extremity amputations in diabetic and non-diabetic patients. A population-based study in Eastern Finland. Diabetes Care 1993, 16, 16-20.
3. Gilmore JE, Allen JA, Hayes JR. Autonomic function in neuropathic diabetic patients with foot ulceration. Diabetes Care, 1993, 16, 61-67.
4. Sternberg M, Cohen-Forterre L and Peyroux J. Connective tissues in diabetes mellitus: biochemical alterations of the intercellular matrix with special reference to Proteoglycans. Diabetes Metab, 1985, 11, 27-50.
5. Gentzkow G, Iwaski SD, Hershon KS et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care, 1996, 4, 350-354.
6. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artificial Organs, 1997, 21, 1203-1210.
7. Sonnenberg FA. Beck R. Markov models in medical decision making. A practical guide. Medical Decision Making, 1993, 13, 322-338.
8. Evans C. The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings. Pharmacoeconomics, 1997, 12, 121-129.
9. Evaluation of the relative cost-effectiveness of Dermagraft® for the treatment of diabetic foot ulcers in France, CRESGE (Lille - France) - York Health Economics Consortium (York - England). Rapport au Ministère de la Santé, Mai 1999.
10. Carpentier et al. Le coût économique du pied diabétique, Diabetes Metab, 1998, suppl (I), XXIV.
11. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot & Ankle International, 1995, 16, 388-394.
12. Mancini L, Ruotolo V. The diabetic Foot, Epidemiology. Rays, 1997, 22, 511-523.
13. Eckman MH et alii. Foot infection in diabetic patients, decision and cost-effectiveness analysis, JAMA, 1995, 273, 712-720.
14. Moriarty KT, Slater N, Welsh C, Hardisty C. The economics of setting up a diabetic foot clinic. Practical Diabetes, 1993, 10, 102-104.
15. Gujral JS, McNally PG, O'Malley BP et al. Ethnic differences in the incidence of lower extremity amputation secondary to diabetes mellitus. Diabet Med, 1993, 10, 271-274.
16. Deerochanawong C, Home PD, Alberti KG. A survey of lower limb amputation in diabetic patients. Diabet Med. 1992, 9, 942-946.
17. Van Houtum WH, Lavery LA, Harkless W. The impact of diabetes-related lower extremety amputations in the Netherlands. J Diabetes Complications, 1996, 10, 325-330.
18. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care, 1983, 6, 87-91.
19. National Diabetes Advisory board. The prevention and treatment of Five Complications of Diabetes. A Guide for Primary Care Practitioners. Atlanta, CDC 1983 (HHS publication no83-8392).
20. Assal JP, Mulhauser I, Pernat A, et al. Patient education as the basis for diabetic care in clinical practice. Diabetologia, 1985, 28, 602-613.
21. Larson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputations in diabetic patients, a consequence of a multi-disciplinary foot care team approach? Diabet Med, 1995, 12, 770-776.
22. Miller AD Van Buskirk A, Verhoek-Oftedahl W, Miller ER. Diabetes-related lower extremity amputations in New Jersey, 1979 to 1981. J Med Soc NJ, 1985, 82, 723-726.
23. Lavery LA, Van Houtum WH, Armstrong DG. Institutionalization following diabetes-related lower extremity amputation. Am J Med, 1997, 103, 383-388.